Osaic Holdings’s Anixa Biosciences ANIX Stock Holding History

Osaic Holdings’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140	Hold	50	–	–	﹤0.01%	7809
2026 Q1	$129	Hold	50	–	–	﹤0.01%	7602
2025 Q4	$156	Hold	50	–	–	﹤0.01%	7604
2025 Q3	$149	Hold	50	–	–	﹤0.01%	7723
2025 Q2	$165	Buy	50 +30	+150%	+$86	﹤0.01%	7526
2025 Q1	$57	Sell	20 -304	-94%	-$869	﹤0.01%	7276
2024 Q4	$751	Sell	324 -1,076	-77%	-$3.34K	﹤0.01%	6914
2024 Q3	$4.41K	Hold	1,400	–	–	﹤0.01%	6271
2024 Q2	$3.09K	Hold	1,400	–	–	﹤0.01%	6413
2024 Q1	$4.37K	Buy	1,400 +1,000	+250%	+$3.99K	﹤0.01%	6152
2023 Q4	$1.55K	Hold	400	–	–	﹤0.01%	6621
2023 Q3	$1.31K	Hold	400	–	–	﹤0.01%	6758
2023 Q2	$1.28K	Hold	400	–	–	﹤0.01%	6808
2023 Q1	$1.72K	Sell	400 -500	-56%	-$2.19K	﹤0.01%	6778
2022 Q4	$4K	Sell	900 -100	-10%	-$481	﹤0.01%	6368
2022 Q3	$4K	Sell	1,000 -900	-47%	-$3.65K	﹤0.01%	6453
2022 Q2	$6K	Buy	1,900 +500	+36%	+$1.58K	﹤0.01%	6365
2022 Q1	$4K	Sell	1,400 -500	-26%	-$1.47K	﹤0.01%	6563
2021 Q4	$6K	Sell	1,900 -2,000	-51%	-$8.09K	﹤0.01%	6519
2021 Q3	$19K	Hold	3,900	–	–	﹤0.01%	5805
2021 Q2	$15K	Hold	3,900	–	–	﹤0.01%	5814
2021 Q1	$18K	Buy	3,900 +2,900	+290%	+$13.9K	﹤0.01%	5543
2020 Q4	$3K	Buy	+1,000	New	+$2.51K	﹤0.01%	5915

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Osaic Holdings's ANIX Position: Q2 2026 in Review

Osaic Holdings held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 50 shares worth $140. The position accounts for ﹤0.01% of the portfolio, ranked #7809.

Osaic Holdings first reported a position in ANIX in Q4 2020 and has held it in 23 quarters since. The position peaked at $19K in Q3 2021. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Osaic Holdings held 50 shares of Anixa Biosciences worth $140 as of Q2 2026.
Osaic Holdings left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7809 holding.
Osaic Holdings first reported a position in Anixa Biosciences in Q4 2020 and has held it in 23 quarters since.
Osaic Holdings's Anixa Biosciences position peaked at $19K in Q3 2021.
63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.